Science Explorer Interactive view Map
Company · La Jolla · United States

MediciNova (United States)

Research works
26
▼ 56% vs 2013–17
Citations
375
14.3 per fractional work
Top-10% rate
13.4%
record average 16.5%
Open access
41%
world 28%

Not ranked overall: MediciNova (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.93× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.27× its world share, 0 worksImmunology and Micro…Neuroscience: 0.79× its world share, 0 worksNeuroscienceMedicine: 2.30× its world share, 2 worksMedicineArts and Humanities: 9.29× its world share, 1 worksArts and HumanitiesSocial Sciences: 0.85× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Arts and Humanities, 9.3×. Every wedge is a field page.

Which keywords describe research at MediciNova (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Treatment, Epidemiology, Genetics, Asthma, Fibrosis, Allergic Diseases and Eosinophils.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 15 words, with their numbers
  1. Inflammation4▲ 6.1×13 topics
  2. Epidemiology3▲ 3.2×12 topics
  3. Treatment2▲ 6.8×7 topics
  4. Genetics2▲ 10.0×2 topics
  5. Asthma2▲ 58×2 topics
  6. Fibrosis2▲ 33×3 topics
  7. Allergic Diseases2▲ 78×1 topic
  8. Eosinophils2▲ 78×1 topic
  9. Idiopathic Pulmonary Fibrosis2▲ 155×1 topic
  10. Interstitial Lung Disease2▲ 110×1 topic
  11. Atherosclerosis1▲ 14×4 topics
  12. Cancer1▲ 3.8×4 topics
  13. Biblical Monotheism1▲ 92×1 topic
  14. Jewish Society1▲ 92×1 topic
  15. Surface Modification1▲ 23×2 topics

Which research topics does MediciNova (United States) publish most on?

By volume in 2022–2025: Biblical Studies and Interpretation, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Cancer, Lipids, and Metabolism and Research in Social Sciences.

  1. 1 Biblical Studies and Interpretation Religious studies 1 works
  2. 2 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
  3. 3 Cancer, Lipids, and Metabolism Cancer Research 0 works
  4. 4 Research in Social Sciences Education 0 works
  5. 5 Cholesterol and Lipid Metabolism Surgery 0 works
  6. 6 Drug Transport and Resistance Mechanisms Oncology 0 works
  7. 7 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
  8. 8 Glioma Diagnosis and Treatment Genetics 0 works
  9. 9 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.2%not open58.8%

World: 28% of research is openly available.

with international co-authors24.4%domestic only75.6%

World: 19% is written across borders.

How has MediciNova (United States)'s research output changed?

Output in 2018–2022 was 56% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in La Jolla

All research institutions in La Jolla

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.